Report Detail

Request for Sample of this report

Service & Software Global Diabetes Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4607022
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Diabetes Software market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The Global Info Research report includes an overview of the development of the Diabetes Software industry chain, the market status of Type 1 Diabetes (For Smartphones, For Tablet PC), Type 2 Diabetes (For Smartphones, For Tablet PC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diabetes Software.
Regionally, the report analyzes the Diabetes Software markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diabetes Software market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Diabetes Software market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diabetes Software industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., For Smartphones, For Tablet PC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diabetes Software market.
Regional Analysis: The report involves examining the Diabetes Software market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diabetes Software market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Diabetes Software:
Company Analysis: Report covers individual Diabetes Software players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diabetes Software This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Type 1 Diabetes, Type 2 Diabetes).
Technology Analysis: Report covers specific technologies relevant to Diabetes Software. It assesses the current state, advancements, and potential future developments in Diabetes Software areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diabetes Software market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Diabetes Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
For Smartphones
For Tablet PC
Web-based
Market segment by Application
Type 1 Diabetes
Type 2 Diabetes
Market segment by players, this report covers
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetes Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetes Software, with revenue, gross margin and global market share of Diabetes Software from 2019 to 2024.
Chapter 3, the Diabetes Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetes Software market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetes Software.
Chapter 13, to describe Diabetes Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Diabetes Software
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Diabetes Software by Type
    • 1.3.1 Overview: Global Diabetes Software Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Diabetes Software Consumption Value Market Share by Type in 2023
    • 1.3.3 For Smartphones
    • 1.3.4 For Tablet PC
    • 1.3.5 Web-based
  • 1.4 Global Diabetes Software Market by Application
    • 1.4.1 Overview: Global Diabetes Software Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Type 1 Diabetes
    • 1.4.3 Type 2 Diabetes
  • 1.5 Global Diabetes Software Market Size & Forecast
  • 1.6 Global Diabetes Software Market Size and Forecast by Region
    • 1.6.1 Global Diabetes Software Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Diabetes Software Market Size by Region, (2019-2030)
    • 1.6.3 North America Diabetes Software Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Diabetes Software Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Diabetes Software Market Size and Prospect (2019-2030)
    • 1.6.6 South America Diabetes Software Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Diabetes Software Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Glooko
    • 2.1.1 Glooko Details
    • 2.1.2 Glooko Major Business
    • 2.1.3 Glooko Diabetes Software Product and Solutions
    • 2.1.4 Glooko Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Glooko Recent Developments and Future Plans
  • 2.2 Accu-Chek (Roche)
    • 2.2.1 Accu-Chek (Roche) Details
    • 2.2.2 Accu-Chek (Roche) Major Business
    • 2.2.3 Accu-Chek (Roche) Diabetes Software Product and Solutions
    • 2.2.4 Accu-Chek (Roche) Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Accu-Chek (Roche) Recent Developments and Future Plans
  • 2.3 Tidepool
    • 2.3.1 Tidepool Details
    • 2.3.2 Tidepool Major Business
    • 2.3.3 Tidepool Diabetes Software Product and Solutions
    • 2.3.4 Tidepool Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Tidepool Recent Developments and Future Plans
  • 2.4 LifeScan, Inc (Platinum Equity)
    • 2.4.1 LifeScan, Inc (Platinum Equity) Details
    • 2.4.2 LifeScan, Inc (Platinum Equity) Major Business
    • 2.4.3 LifeScan, Inc (Platinum Equity) Diabetes Software Product and Solutions
    • 2.4.4 LifeScan, Inc (Platinum Equity) Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 LifeScan, Inc (Platinum Equity) Recent Developments and Future Plans
  • 2.5 Pharmaco Diabetes
    • 2.5.1 Pharmaco Diabetes Details
    • 2.5.2 Pharmaco Diabetes Major Business
    • 2.5.3 Pharmaco Diabetes Diabetes Software Product and Solutions
    • 2.5.4 Pharmaco Diabetes Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pharmaco Diabetes Recent Developments and Future Plans
  • 2.6 Ascensia Diabetes Care Holdings AG
    • 2.6.1 Ascensia Diabetes Care Holdings AG Details
    • 2.6.2 Ascensia Diabetes Care Holdings AG Major Business
    • 2.6.3 Ascensia Diabetes Care Holdings AG Diabetes Software Product and Solutions
    • 2.6.4 Ascensia Diabetes Care Holdings AG Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ascensia Diabetes Care Holdings AG Recent Developments and Future Plans
  • 2.7 Diabeto Medtech India Pvt. Ltd
    • 2.7.1 Diabeto Medtech India Pvt. Ltd Details
    • 2.7.2 Diabeto Medtech India Pvt. Ltd Major Business
    • 2.7.3 Diabeto Medtech India Pvt. Ltd Diabetes Software Product and Solutions
    • 2.7.4 Diabeto Medtech India Pvt. Ltd Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Diabeto Medtech India Pvt. Ltd Recent Developments and Future Plans
  • 2.8 Abbott Diabetes Care
    • 2.8.1 Abbott Diabetes Care Details
    • 2.8.2 Abbott Diabetes Care Major Business
    • 2.8.3 Abbott Diabetes Care Diabetes Software Product and Solutions
    • 2.8.4 Abbott Diabetes Care Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abbott Diabetes Care Recent Developments and Future Plans
  • 2.9 Acon Diabetes Care International
    • 2.9.1 Acon Diabetes Care International Details
    • 2.9.2 Acon Diabetes Care International Major Business
    • 2.9.3 Acon Diabetes Care International Diabetes Software Product and Solutions
    • 2.9.4 Acon Diabetes Care International Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Acon Diabetes Care International Recent Developments and Future Plans
  • 2.10 BIONIME
    • 2.10.1 BIONIME Details
    • 2.10.2 BIONIME Major Business
    • 2.10.3 BIONIME Diabetes Software Product and Solutions
    • 2.10.4 BIONIME Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 BIONIME Recent Developments and Future Plans
  • 2.11 Custo med
    • 2.11.1 Custo med Details
    • 2.11.2 Custo med Major Business
    • 2.11.3 Custo med Diabetes Software Product and Solutions
    • 2.11.4 Custo med Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Custo med Recent Developments and Future Plans
  • 2.12 Dexcom
    • 2.12.1 Dexcom Details
    • 2.12.2 Dexcom Major Business
    • 2.12.3 Dexcom Diabetes Software Product and Solutions
    • 2.12.4 Dexcom Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Dexcom Recent Developments and Future Plans
  • 2.13 Dottli
    • 2.13.1 Dottli Details
    • 2.13.2 Dottli Major Business
    • 2.13.3 Dottli Diabetes Software Product and Solutions
    • 2.13.4 Dottli Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Dottli Recent Developments and Future Plans
  • 2.14 GlucoMe
    • 2.14.1 GlucoMe Details
    • 2.14.2 GlucoMe Major Business
    • 2.14.3 GlucoMe Diabetes Software Product and Solutions
    • 2.14.4 GlucoMe Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 GlucoMe Recent Developments and Future Plans
  • 2.15 MyLife
    • 2.15.1 MyLife Details
    • 2.15.2 MyLife Major Business
    • 2.15.3 MyLife Diabetes Software Product and Solutions
    • 2.15.4 MyLife Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 MyLife Recent Developments and Future Plans
  • 2.16 Nova
    • 2.16.1 Nova Details
    • 2.16.2 Nova Major Business
    • 2.16.3 Nova Diabetes Software Product and Solutions
    • 2.16.4 Nova Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Nova Recent Developments and Future Plans
  • 2.17 Tandem Diabetes Care
    • 2.17.1 Tandem Diabetes Care Details
    • 2.17.2 Tandem Diabetes Care Major Business
    • 2.17.3 Tandem Diabetes Care Diabetes Software Product and Solutions
    • 2.17.4 Tandem Diabetes Care Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Tandem Diabetes Care Recent Developments and Future Plans
  • 2.18 Trividia Health
    • 2.18.1 Trividia Health Details
    • 2.18.2 Trividia Health Major Business
    • 2.18.3 Trividia Health Diabetes Software Product and Solutions
    • 2.18.4 Trividia Health Diabetes Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Trividia Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Diabetes Software Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Diabetes Software by Company Revenue
    • 3.2.2 Top 3 Diabetes Software Players Market Share in 2023
    • 3.2.3 Top 6 Diabetes Software Players Market Share in 2023
  • 3.3 Diabetes Software Market: Overall Company Footprint Analysis
    • 3.3.1 Diabetes Software Market: Region Footprint
    • 3.3.2 Diabetes Software Market: Company Product Type Footprint
    • 3.3.3 Diabetes Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Diabetes Software Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Diabetes Software Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Diabetes Software Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Diabetes Software Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Diabetes Software Consumption Value by Type (2019-2030)
  • 6.2 North America Diabetes Software Consumption Value by Application (2019-2030)
  • 6.3 North America Diabetes Software Market Size by Country
    • 6.3.1 North America Diabetes Software Consumption Value by Country (2019-2030)
    • 6.3.2 United States Diabetes Software Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Diabetes Software Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Diabetes Software Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Diabetes Software Consumption Value by Type (2019-2030)
  • 7.2 Europe Diabetes Software Consumption Value by Application (2019-2030)
  • 7.3 Europe Diabetes Software Market Size by Country
    • 7.3.1 Europe Diabetes Software Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Diabetes Software Market Size and Forecast (2019-2030)
    • 7.3.3 France Diabetes Software Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Diabetes Software Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Diabetes Software Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Diabetes Software Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Diabetes Software Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Diabetes Software Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Diabetes Software Market Size by Region
    • 8.3.1 Asia-Pacific Diabetes Software Consumption Value by Region (2019-2030)
    • 8.3.2 China Diabetes Software Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Diabetes Software Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Diabetes Software Market Size and Forecast (2019-2030)
    • 8.3.5 India Diabetes Software Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Diabetes Software Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Diabetes Software Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Diabetes Software Consumption Value by Type (2019-2030)
  • 9.2 South America Diabetes Software Consumption Value by Application (2019-2030)
  • 9.3 South America Diabetes Software Market Size by Country
    • 9.3.1 South America Diabetes Software Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Diabetes Software Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Diabetes Software Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Diabetes Software Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Diabetes Software Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Diabetes Software Market Size by Country
    • 10.3.1 Middle East & Africa Diabetes Software Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Diabetes Software Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Diabetes Software Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Diabetes Software Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Diabetes Software Market Drivers
  • 11.2 Diabetes Software Market Restraints
  • 11.3 Diabetes Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Diabetes Software Industry Chain
  • 12.2 Diabetes Software Upstream Analysis
  • 12.3 Diabetes Software Midstream Analysis
  • 12.4 Diabetes Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Diabetes Software. Industry analysis & Market Report on Diabetes Software is a syndicated market report, published as Global Diabetes Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Diabetes Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo